Open AccessTesticular sperm extraction in a patient with ejaculatory dysfunction after combined androgen blockade therapy for prostate cancer
Author(s) -
Amano Toshiyasu,
Suzuki Chihiro,
Shimojima Yuji,
Imao Tetsuya,
Earle Carolyn
Publication year - 2020
Publication title -
iju case reports
Language(s) - English
Resource type - Journals
ISSN - 2577-171X
DOI - 10.1002/iju5.12176
Subject(s) - prostate cancer , medicine , discontinuation , urology , sperm , fertility , testicular sperm extraction , prostate , blockade , hormonal therapy , sexual dysfunction , radiation therapy , gynecology , erectile dysfunction , cancer , oncology , infertility , azoospermia , andrology , pregnancy , population , biology , receptor , environmental health , genetics
Prostate cancer is the most prevalent urological cancer for older men. However, there is still a possibility that a few prostate cancer patients may still wish to have children. Case presentation A 49‐year‐old male was diagnosed with low‐risk prostate cancer. Combined anti‐androgen blockade therapy was performed for 8 months prior to radiation therapy. However, he suffered from ejaculatory dysfunction and wished to conceive with his partner. Hormonal therapy was discontinued and he was referred to our clinic for sperm preservation. His ejaculatory function did not recover after 4 months discontinuation of hormonal therapy, subsequently micro‐testicular sperm extraction for sperm preservation was successfully performed. Conclusion Sperm preservation in patients with prostate cancer is unusual but it should be considered if the patient’s fertility is an issue.